Evidence map›Paper›PMID 32825710›Full record

ReviewNutrients2020

Select Polyphenol-Rich Berry Consumption to Defer or Deter Diabetes and Diabetes-Related Complications.

Ahsan Hameed, Mauro Galli, Edyta Adamska-Patruno, Adam Krętowski, Michal Ciborowski

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Journal of pharmaceutical analysis · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Supplementation ofMicroorganisms · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Antihyperglycemic and Antidyslipidemic Effect ofCardiovascular & hematological disorders drug targets · 2022
    Article
  18. Article
  19. Article
  20. Anti-Obesity Effects ofFoods (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ahsan HameedClinical Research Center, Medical University of Bialystok, 15-089 Bialystok, Poland.
Mauro GalliDepartment of Medical Biology, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0003-3871-8125
Edyta Adamska-PatrunoClinical Research Center, Medical University of Bialystok, 15-089 Bialystok, Poland.
Adam KrętowskiClinical Research Center, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0002-4522-4978
Michal CiborowskiClinical Research Center, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0003-3729-0518
Medical University of Białystok · PL

Funding

Horizon 2020 Framework Programme 754432
6 · The paper itself

Abstract

Berries are considered "promising functional fruits" due to their distinct and ubiquitous therapeutic contents of anthocyanins, proanthocyanidins, phenolic acids, flavonoids, flavanols, alkaloids, polysaccharides, hydroxycinnamic, ellagic acid derivatives, and organic acids. These polyphenols are part of berries and the human diet, and evidence suggests that their intake is associated with a reduced risk or the reversal of metabolic pathophysiologies related to diabetes, obesity, oxidative stress, inflammation, and hypertension. This work reviewed and summarized both clinical and non-clinical findings that the consumption of berries, berry extracts, purified compounds, juices, jams, jellies, and other berry byproducts aided in the prevention and or otherwise management of type 2 diabetes mellitus (T2DM) and related complications. The integration of berries and berries-derived byproducts into high-carbohydrate (HCD) and high-fat (HFD) diets, also reversed/reduced the HCD/HFD-induced alterations in glucose metabolism-related pathways, and markers of oxidative stress, inflammation, and lipid oxidation in healthy/obese/diabetic subjects. The berry polyphenols also modulate the intestinal microflora ecology by opposing the diabetic and obesity rendered symbolic reduction of Bacteroidetes/Firmicutes ratio, intestinal mucosal barrier dysfunction-restoring bacteria, short-chain fatty acids, and organic acid producing microflora. All studies proposed a number of potential mechanisms of action of respective berry bioactive compounds, although further mechanistic and molecular studies are warranted. The metabolic profiling of each berry is also included to provide up-to-date information regarding the potential anti-oxidative/antidiabetic constituents of each berry.

Indexed as

AntioxidantsDietary SupplementsFunctional FoodHypoglycemic AgentsPhytotherapyAnthocyaninsDiabetes Mellitus, Type 2EatingFlavonoidsFruitHumansHyperglycemiaHyperlipidemiasMetabolic SyndromeNutritional Physiological PhenomenaOxidative StressAnthocyaninsAntioxidantsFlavonoidsHypoglycemic AgentsPolyphenolsproanthocyanidinProanthocyanidinsberriesdiabetesgenomicshyperglycemiahyperlipidemiametabolic syndromemetabolomicsomicsprecision nutrition

Identifiers

PMID32825710
PMCPMC7551116
OpenAlexW3080807395

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.